152 related articles for article (PubMed ID: 15558022)
1. beta-Catenin activates the growth factor endothelin-1 in colon cancer cells.
Kim TH; Xiong H; Zhang Z; Ren B
Oncogene; 2005 Jan; 24(4):597-604. PubMed ID: 15558022
[TBL] [Abstract][Full Text] [Related]
2. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
[TBL] [Abstract][Full Text] [Related]
3. Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis.
Takahashi M; Fujita M; Furukawa Y; Hamamoto R; Shimokawa T; Miwa N; Ogawa M; Nakamura Y
Cancer Res; 2002 Oct; 62(20):5651-6. PubMed ID: 12384519
[TBL] [Abstract][Full Text] [Related]
4. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association.
Nath N; Kashfi K; Chen J; Rigas B
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12584-9. PubMed ID: 14566053
[TBL] [Abstract][Full Text] [Related]
6. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
Tetsu O; McCormick F
Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
[TBL] [Abstract][Full Text] [Related]
7. Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells.
Chen RH; McCormick F
Cancer Res; 2001 Jun; 61(11):4445-9. PubMed ID: 11389074
[TBL] [Abstract][Full Text] [Related]
8. Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells.
Sun P; Xiong H; Kim TH; Ren B; Zhang Z
Mol Pharmacol; 2006 Feb; 69(2):520-31. PubMed ID: 16291872
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.
Pálmer HG; González-Sancho JM; Espada J; Berciano MT; Puig I; Baulida J; Quintanilla M; Cano A; de Herreros AG; Lafarga M; Muñoz A
J Cell Biol; 2001 Jul; 154(2):369-87. PubMed ID: 11470825
[TBL] [Abstract][Full Text] [Related]
10. Synergistic cooperation between the beta-catenin signaling pathway and steroidogenic factor 1 in the activation of the Mullerian inhibiting substance type II receptor.
Hossain A; Saunders GF
J Biol Chem; 2003 Jul; 278(29):26511-6. PubMed ID: 12724325
[TBL] [Abstract][Full Text] [Related]
11. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.
Morin PJ; Sparks AB; Korinek V; Barker N; Clevers H; Vogelstein B; Kinzler KW
Science; 1997 Mar; 275(5307):1787-90. PubMed ID: 9065402
[TBL] [Abstract][Full Text] [Related]
12. TIP49 regulates beta-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling.
Feng Y; Lee N; Fearon ER
Cancer Res; 2003 Dec; 63(24):8726-34. PubMed ID: 14695187
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors.
Yan D; Wiesmann M; Rohan M; Chan V; Jefferson AB; Guo L; Sakamoto D; Caothien RH; Fuller JH; Reinhard C; Garcia PD; Randazzo FM; Escobedo J; Fantl WJ; Williams LT
Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14973-8. PubMed ID: 11752446
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the beta-catenin/T-cell factor complex, in colorectal carcinomas.
Fujita M; Furukawa Y; Tsunoda T; Tanaka T; Ogawa M; Nakamura Y
Cancer Res; 2001 Nov; 61(21):7722-6. PubMed ID: 11691783
[TBL] [Abstract][Full Text] [Related]
15. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M
Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729
[TBL] [Abstract][Full Text] [Related]
16. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A
Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
Esufali S; Bapat B
Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the beta-catenin binding domain of cadherin selectively kills colorectal cancer cells.
Pierce M; Wang C; Stump M; Kamb A
Int J Cancer; 2003 Nov; 107(2):229-37. PubMed ID: 12949799
[TBL] [Abstract][Full Text] [Related]
19. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
Alves-Guerra MC; Ronchini C; Capobianco AJ
Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
[TBL] [Abstract][Full Text] [Related]
20. Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers.
Takahashi M; Tsunoda T; Seiki M; Nakamura Y; Furukawa Y
Oncogene; 2002 Aug; 21(38):5861-7. PubMed ID: 12185585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]